Healthcare provider profile · identity verified

Alejandro Torres, MD

Internal Medicine · FRESNO, CA · NPI 1720572704

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1018	367
Metformin Hcl	Metformin Hcl	593	225
Lisinopril	Lisinopril	536	188
Amlodipine Besylate	Amlodipine Besylate	471	168
Hydrochlorothiazide	Hydrochlorothiazide	361	124
Gabapentin	Gabapentin	340	122
Omeprazole	Omeprazole	337	111
Levothyroxine Sodium	Levothyroxine Sodium	316	104
Glipizide	Glipizide	302	112
Losartan Potassium	Losartan Potassium	301	106
Ibuprofen	Ibuprofen	288	144
Metoprolol Succinate	Metoprolol Succinate	223	77
Fluticasone Propionate	Fluticasone Propionate	199	105
Tamsulosin Hcl	Tamsulosin Hcl	182	74
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	172	62
Albuterol Sulfate Hfa	Albuterol Sulfate	167	77
Ozempic	Semaglutide	128	32
Jardiance	Empagliflozin	118	44
Furosemide	Furosemide	110	43
Sertraline Hcl	Sertraline Hcl	109	32
Diclofenac Sodium	Diclofenac Sodium	108	65
Januvia	Sitagliptin Phosphate	105	36
Trulicity	Dulaglutide	99	19
Pantoprazole Sodium	Pantoprazole Sodium	95	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	28
Carvedilol	Carvedilol	89	29
Pravastatin Sodium	Pravastatin Sodium	86	28
Meclizine Hcl	Meclizine Hcl	83	50
Pioglitazone Hcl	Pioglitazone Hcl	79	25
Simvastatin	Simvastatin	74	24
Montelukast Sodium	Montelukast Sodium	72	22
Rosuvastatin Calcium	Rosuvastatin Calcium	69	26
Alendronate Sodium	Alendronate Sodium	68	31
Metoprolol Tartrate	Metoprolol Tartrate	68	27
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	67	26
Chlorthalidone	Chlorthalidone	59	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	22
Clopidogrel	Clopidogrel Bisulfate	57	22
Eliquis	Apixaban	56	15
Naproxen	Naproxen	54	25
Meloxicam	Meloxicam	53	24
Trazodone Hcl	Trazodone Hcl	53	22
Famotidine	Famotidine	52	20
Fenofibrate	Fenofibrate	51	20
Finasteride	Finasteride	51	22
Allopurinol	Allopurinol	50	21
Triamcinolone Acetonide	Triamcinolone Acetonide	50	33
Breyna	Budesonide/Formoterol Fumarate	49	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	25
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	45	27
Enalapril Maleate	Enalapril Maleate	43	12
Farxiga	Dapagliflozin Propanediol	39	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	29
Prednisone	Prednisone	38	27
Vitamin D2	Ergocalciferol (Vitamin D2)	37	25
Xarelto	Rivaroxaban	37	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	20
Pregabalin	Pregabalin	35	suppressed
Atenolol	Atenolol	34	12
Levetiracetam	Levetiracetam	34	suppressed
Mirtazapine	Mirtazapine	34	15
Glimepiride	Glimepiride	33	12
Nifedipine Er	Nifedipine	33	12
Azelastine Hcl	Azelastine Hcl	32	21
Celecoxib	Celecoxib	31	11
Hydralazine Hcl	Hydralazine Hcl	31	13
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Azithromycin	Azithromycin	28	23
Ezetimibe	Ezetimibe	28	11
Spironolactone	Spironolactone	27	11
Novolog Flexpen	Insulin Aspart	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Lidocaine	Lidocaine	22	13
Baclofen	Baclofen	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	11
Lovastatin	Lovastatin	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Dutasteride	Dutasteride	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Phenobarbital	Phenobarbital	17	suppressed
Valsartan	Valsartan	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	11
Potassium Chloride	Potassium Chloride	14	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Irbesartan	Irbesartan	13	suppressed
Loperamide	Loperamide Hcl	13	11
Ondansetron Odt	Ondansetron	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lactulose	Lactulose	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	11	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error